DABRAFENIB | DABRAFENIB | ATC L01XE23
ANTINEOPLASTIC MELANOMA WITH BRAF V600E INHIBITOR | ORAL | F 95 PERCENT VD 70.3 LITER PPB 99.7 PERCENT Cl 25.7 LITER / HOUR HT 8 HOUR SOLUBILITY PRACTICALLY INSOLUBLE ABOVE PH 4 | BRAF V600E KINASE (IC50=0.65 NANOMOLAR) BRAF V600K (IC50=0.5 NANOMOLAR) BRAF V600D (IC50=1.84 NANOMOLAR) WILD-TYPE BRAF (3.2 NANOMOLAR) CRAF KINASE (5 NANOMOLAR) PDB 5CSW (B-RAF IN COMPLEX WITH DABRAFENIB) LIGAND CODE = P06 (link to the list of PDB complexes) Download experimental 3D coordinates of P06 with added hydrogens | SERINE/THREONINE-PROTEIN KINASE B-RAF INHIBITOR CHEMBL5145 SERINE/THREONINE-PROTEIN KINASE B-RAF P15056 SERINE/THREONINE-PROTEIN KINASE B-RAF HOMO SAPIENS ENZYME KINASE PROTEIN KINASE TKL RAF | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |